Tranilast Market to Reach USD 228 Million by 2032 at 6% CAGR – Anti-Inflammatory Demand Surges

Global Tranilast market expands from USD 143 million in 2024, driven by asthma, keloid, and scar treatments. North America leads with advanced R Asia-Pacific grows fastest via China/India pharma hubs. Purity 98%-99% variants fuel medication (primary) and chemical applications; Daiwa, Cayman Chemical dominate amid dermatology and precision medicine innovations

Read our full Report: https://www.24chemicalresearch.....com/reports/292491/